Phospho-Histone H2A.X (Tyr142) Antibody

What is Histone H2A.X and its significance in genomic research?

Histone H2A.X is a specialized variant of the H2A histone family, which constitutes one of the four core histones forming the nucleosome core particle in eukaryotes. This variant plays a critical role in DNA damage response pathways, particularly in signaling and recruiting repair proteins to DNA double-strand breaks (DSBs). H2A.X contains 143 amino acid residues and is considered a basal histone, being synthesized in both G1 and S-phase of the cell cycle . Unlike standard histones, H2A.X mRNA exists in two forms: a longer 1600-base form containing a polyA tail and a shorter 575-base form lacking polyA, allowing for both replication-dependent and independent expression . The significance of H2A.X lies in its post-translational modifications that serve as key signaling mechanisms in DNA damage response pathways, making it an essential target for genomic integrity research .

What distinguishes the phosphorylation of Tyr142 from other H2A.X phosphorylation sites?

The phosphorylation of Tyr142 represents a unique regulatory mechanism distinct from the better-known Ser139 phosphorylation (γH2A.X). While Ser139 phosphorylation occurs in response to DNA damage, Tyr142 is constitutively phosphorylated under basal conditions by the Williams-Beuren syndrome transcription factor (WSTF), a component of the WSTF-ISWI chromatin-remodeling complex (WICH) . Following DNA damage, Tyr142 undergoes progressive dephosphorylation by the Eya1 and Eya3 tyrosine phosphatases, creating a temporal signaling dynamic . This contrasting behavior—where Ser139 becomes phosphorylated while Tyr142 becomes dephosphorylated in response to DNA damage—establishes a phosphorylation code that determines cellular fate after DNA damage . The unique position of Tyr142 at the C-terminal end of H2A.X also contributes to its distinct regulatory properties and interaction with specific damage response proteins .

How does the dual phosphorylation state of H2A.X influence cellular outcomes after DNA damage?

The dual phosphorylation state of H2A.X (pSer139/pTyr142) functions as a molecular switch that determines cell fate following DNA damage. Initially after DNA damage, H2A.X exists in a diphosphorylated state (pSer139/pTyr142), which gradually transitions to a monophosphorylated state (pSer139) as Tyr142 becomes dephosphorylated by Eya1/3 phosphatases . This transition influences whether cells undergo DNA repair or apoptosis. The diphosphorylated state appears to favor recruitment of pro-apoptotic factors, whereas the monophosphorylated state (pSer139 only) predominantly recruits DNA repair factors . This temporal switch mechanism allows cells to initially evaluate the extent of damage before committing to repair, and if repair is unsuccessful or damage is extensive, to trigger apoptotic pathways . Mediator proteins like MCPH1 (Microcephalin) can recognize both states via its tandem BRCT domains, serving as versatile sensors of these H2A.X phosphorylation marks .

What are the optimal methods for detecting Phospho-Histone H2A.X (Tyr142) in different experimental systems?

Detection of Phospho-Histone H2A.X (Tyr142) can be achieved through several complementary techniques, each with specific advantages depending on the experimental context:

Western Blotting: For quantitative assessment of global phosphorylation levels, Western blotting using specific anti-Phospho-H2A.X (Tyr142) antibodies at a dilution of 1:1000 is recommended . This approach allows for evaluation of the total cellular levels of the modification but lacks spatial resolution.

Immunofluorescence: For visualizing the spatial distribution of Phospho-H2A.X (Tyr142) within cells, immunofluorescence microscopy using antibodies at 1:100 dilution provides excellent cellular resolution . This method is particularly valuable for determining localization patterns relative to other nuclear proteins or structures.

Flow Cytometry: When quantitative analysis of Phospho-H2A.X (Tyr142) at the single-cell level is needed, flow cytometry with fixed/permeabilized cells and antibody dilution of 1:200 allows for high-throughput assessment and potential correlation with cell cycle phases .

Immunoprecipitation: For studying protein interactions with Phospho-H2A.X (Tyr142), immunoprecipitation using a 1:50 antibody dilution can isolate complexes containing this modified histone for subsequent analysis .

The choice of method should be guided by the specific research question, with consideration for temporal dynamics of the modification and potential cross-reactivity with other phosphorylated residues.

How can researchers effectively distinguish between Tyr142 and Ser139 phosphorylation states in experimental settings?

Effectively distinguishing between Tyr142 and Ser139 phosphorylation requires careful selection of methodological approaches:

When using immunological detection methods, researchers should employ antibodies specifically validated for their target phosphorylation site. For comprehensive analysis, dual-specificity antibodies recognizing both phosphorylation states (pSer139/pTyr142) can be valuable for identifying the diphosphorylated species . To confirm specificity, control experiments using phosphatase treatments or site-directed mutants (S139A, Y142F) should be included to validate signals . For temporal studies tracking the dynamic relationship between these modifications, time-course experiments with site-specific antibodies provide the most reliable data on their relative appearance and disappearance following DNA damage .

What controls are essential when using Phospho-Histone H2A.X (Tyr142) Antibody in research?

When utilizing Phospho-Histone H2A.X (Tyr142) Antibody in research, the following controls are essential for ensuring experimental validity:

Positive Controls:

• Treatment with DNA damaging agents (such as ionizing radiation) to induce the dynamic phosphorylation changes in H2A.X

• Cell lines with known high expression of WSTF (the kinase responsible for Tyr142 phosphorylation)

• Recombinant H2A.X protein phosphorylated at Tyr142 for antibody validation

Negative Controls:

• Cell lines expressing Y142F mutant H2A.X (cannot be phosphorylated at this position)

• Phosphatase-treated samples to remove the modification

• Blocking peptide competition assays to confirm antibody specificity

• Pre-immunization serum (for polyclonal antibodies)

Validation Controls:

• Parallel detection with alternative antibodies targeting the same modification

• Correlation with mass spectrometry data

• Kinase inhibitor studies (targeting WSTF) to reduce the modification

• EYA phosphatase inhibition to maintain phosphorylation

Additionally, species cross-reactivity should be confirmed when working with non-human models, as the antibody may show different reactivity patterns across species . These controls collectively ensure that observed signals genuinely represent Tyr142 phosphorylation rather than experimental artifacts or cross-reactivity with other modifications.

How does the temporal dynamics of Tyr142 dephosphorylation correlate with DNA repair pathway choice?

The temporal dynamics of Tyr142 dephosphorylation plays a crucial role in determining DNA repair pathway choice and cellular outcomes following DNA damage. Research indicates that the progressive dephosphorylation of Tyr142 by Eya1/3 phosphatases occurs with distinct kinetics that influence downstream signaling cascades :

Early Phase (0-30 minutes post-damage):

• H2A.X maintains dual phosphorylation (pSer139/pTyr142)

• Initial assessment of damage extent occurs

• Checkpoint proteins begin to accumulate at damage sites

• Cell cycle arrest is initiated

Intermediate Phase (30-120 minutes post-damage):

• Gradual dephosphorylation of Tyr142 occurs

• Transition from pro-apoptotic signaling toward repair pathways

• MDC1 recruitment increases as Tyr142 phosphorylation decreases

• DNA repair complex assembly accelerates

Late Phase (>120 minutes post-damage):

• Predominantly monophosphorylated state (pSer139)

• Full engagement of repair machinery or commitment to apoptosis

• Resolution of repair or amplification of apoptotic signaling

This temporal switch influences whether homologous recombination (HR) or non-homologous end joining (NHEJ) pathways are activated for repair, with evidence suggesting that the diphosphorylated state may inhibit NHEJ components while the monophosphorylated state promotes their recruitment . Importantly, MCPH1, an early DNA damage response protein, can recognize both phosphorylation states, potentially serving as a sensor for this temporal transition and guiding subsequent protein recruitment .

What is the relationship between MCPH1 (Microcephalin) binding to H2A.X and the phosphorylation status of Tyr142?

The relationship between MCPH1 (Microcephalin) binding to H2A.X and the phosphorylation status of Tyr142 represents a sophisticated mechanism for interpreting the H2A.X phosphorylation code. Structural and biochemical evidence demonstrates that MCPH1, through its tandem BRCA1 C-terminal (BRCT) domains, possesses the remarkable ability to recognize both the diphosphorylated (pSer139/pTyr142) and monophosphorylated (pSer139) states of H2A.X . This dual recognition capability makes MCPH1 a versatile sensor of H2A.X phosphorylation marks throughout the DNA damage response process.

The BRCT domains of MCPH1 contain binding pockets that can accommodate the phosphorylated Ser139 residue while simultaneously interacting with the phosphorylated Tyr142 residue when present . This structural arrangement allows MCPH1 to maintain association with H2A.X regardless of the Tyr142 phosphorylation status, ensuring continuous signaling as the cell transitions from damage detection to repair initiation .

Cellular evidence confirms that MCPH1 recruitment to DNA damage sites correlates with both phosphorylation states of H2A.X, suggesting that MCPH1 may serve as an initial responder that helps coordinate the temporal transition between early damage signaling and subsequent repair factor recruitment . This unique binding capacity distinguishes MCPH1 from other damage response mediators that may show preference for either the diphosphorylated or monophosphorylated state.

How can researchers study the interplay between Tyr142 and Ser139 phosphorylation in the context of competing DNA repair and apoptotic pathways?

Investigating the interplay between Tyr142 and Ser139 phosphorylation in the context of competing DNA repair and apoptotic pathways requires sophisticated experimental approaches:

Time-resolved Phosphorylation Analysis:

• Synchronize DNA damage induction using controlled methods (laser microirradiation or radiomimetic drugs)

• Collect samples at multiple timepoints (0, 15, 30, 60, 120, 240 minutes post-damage)

• Use site-specific antibodies to track both modifications simultaneously

• Correlate phosphorylation status with recruitment of repair (MDC1, 53BP1) and apoptotic factors (JNK1)

Genetic Manipulation Approaches:

• Generate cell lines expressing phospho-mimetic (Y142E) or phospho-deficient (Y142F) H2A.X mutants

• Create WSTF (kinase) or EYA1/3 (phosphatases) knockdown/knockout cell lines

• Develop inducible systems to control the timing of phosphorylation/dephosphorylation

• Utilize CRISPR-Cas9 to introduce specific mutations at endogenous loci

Proteomic Investigation:

• Perform immunoprecipitation with modification-specific antibodies followed by mass spectrometry

• Utilize proximity labeling techniques (BioID, APEX) with H2A.X as bait

• Conduct chromatin proteomics to identify differential protein recruitment to modified H2A.X

• Employ crosslinking mass spectrometry to detect direct interaction partners

Functional Outcome Assessment:

• Measure repair efficiency using reporter assays for HR and NHEJ pathways

• Quantify apoptosis markers in relation to phosphorylation status

• Assess cell survival following different degrees of DNA damage

• Evaluate checkpoint recovery in cells with altered phosphorylation dynamics

By integrating these approaches, researchers can establish causal relationships between the phosphorylation status of H2A.X and downstream pathway activation, providing insight into how this molecular switch determines cellular fate after DNA damage .

What are common pitfalls when working with Phospho-Histone H2A.X (Tyr142) Antibody and how can they be addressed?

Working with Phospho-Histone H2A.X (Tyr142) Antibody presents several technical challenges that researchers should anticipate and address:

Issue: Cross-reactivity with phosphorylated Ser139

• Solution: Perform validation using Y142F mutants to confirm specificity

• Solution: Include phosphopeptide competition assays to verify binding site

• Solution: Compare results using multiple antibodies from different sources

Issue: Loss of phosphorylation during sample preparation

• Solution: Include phosphatase inhibitors in all buffers (sodium fluoride, sodium orthovanadate)

• Solution: Process samples rapidly at cold temperatures

• Solution: Consider fixation methods that preserve phosphorylation status

Issue: Background signals in immunostaining

• Solution: Optimize fixation protocols (avoid overfixation with formaldehyde)

• Solution: Increase blocking time and concentration

• Solution: Validate antibody dilution ratios for each application

• Solution: Consider alternative detection systems

Issue: Inconsistent Western blot results

• Solution: Use appropriate extraction methods for histones (acid extraction)

• Solution: Consider alternative transfer methods optimized for small proteins

• Solution: Verify gel percentage (15-18% recommended for histones)

• Solution: Include loading controls specific for histone content

Issue: Difficulty detecting basal Tyr142 phosphorylation

• Solution: Avoid phosphatase treatment during sample preparation

• Solution: Increase antibody concentration or incubation time

• Solution: Use enhanced chemiluminescence detection systems

• Solution: Consider enrichment of histones prior to analysis

By anticipating these challenges and implementing appropriate technical solutions, researchers can generate more reliable and reproducible data when working with Phospho-Histone H2A.X (Tyr142) Antibody .

How can researchers optimize immunofluorescence protocols for simultaneous detection of pTyr142 and pSer139?

Optimizing immunofluorescence protocols for simultaneous detection of pTyr142 and pSer139 in H2A.X requires careful consideration of several technical parameters:

Fixation Optimization:

• Use 4% paraformaldehyde for 10-15 minutes (avoid overfixation)

• Consider dual fixation with brief methanol treatment (30 seconds at -20°C) after paraformaldehyde to improve epitope accessibility

• Include phosphatase inhibitors in fixation buffers

Antibody Selection and Validation:

• Choose primary antibodies raised in different host species (e.g., rabbit anti-pTyr142 and mouse anti-pSer139)

• Validate antibodies individually before attempting co-staining

• Test for cross-reactivity and competition between antibodies

• Consider using directly conjugated primary antibodies if signal interference occurs

Sequential Staining Protocol:

• Permeabilize cells with 0.2% Triton X-100 for 10 minutes

• Block with 5% BSA containing phosphatase inhibitors for 1 hour

• Apply first primary antibody (typically anti-pSer139) at 1:100 dilution overnight at 4°C

• Wash extensively (4× for 10 minutes each)

• Apply first secondary antibody for 1 hour at room temperature

• Wash extensively (4× for 10 minutes each)

• Apply second primary antibody (anti-pTyr142) at 1:100 dilution for 4 hours at room temperature

• Wash extensively (4× for 10 minutes each)

• Apply second secondary antibody for 1 hour at room temperature

• Counterstain nucleus and mount with anti-fade mounting medium

Signal Optimization:

• Use tyramide signal amplification for detecting low-abundance modifications

• Optimize exposure settings to account for potential differences in signal intensity

• Consider spectral unmixing if fluorophores have overlapping emission spectra

• Include single-stained controls to establish proper exposure settings

Imaging Considerations:

• Utilize confocal microscopy for precise co-localization studies

• Apply deconvolution algorithms to improve signal resolution

• Consider super-resolution techniques for detailed co-localization analysis

By following these optimization strategies, researchers can achieve reliable simultaneous detection of both phosphorylation marks, enabling detailed analysis of their spatial and temporal relationships within the cell nucleus .

What considerations should researchers take into account when studying Phospho-H2A.X (Tyr142) across different species or cell types?

When studying Phospho-H2A.X (Tyr142) across different species or cell types, researchers should consider several important factors to ensure valid and interpretable results:

Species-Specific Sequence Variations:

• Confirm H2A.X sequence homology in the C-terminal region containing Tyr142

• Validate antibody cross-reactivity experimentally for each species

• Note that while the antibody is predicted to react with mouse and rat based on sequence homology , validation is still necessary

• Consider using species-specific antibodies when available

Cell Type Considerations:

• Account for variations in basal Tyr142 phosphorylation levels across cell types

• Recognize that WSTF (the kinase) and EYA1/3 (phosphatases) expression varies by cell type

• Adjust protein extraction protocols based on cell type (e.g., primary neurons vs. cancer cell lines)

• Establish appropriate baseline controls specific to each cell type

Technical Adjustments:

• Optimize fixation conditions based on cell type (adherent vs. suspension cells)

• Adjust permeabilization protocols for different nuclear membrane properties

• Consider cell-specific autofluorescence when designing imaging experiments

• Modify antibody concentrations and incubation times based on target abundance

Biological Context Variations:

• Account for differences in DNA damage response pathways across species

• Recognize that the kinetics of Tyr142 dephosphorylation may vary by cell type

• Consider cell cycle distribution differences between proliferating and non-proliferating cells

• Evaluate the potential impact of differentiation state on H2A.X modifications

Validation Strategies:

• Include positive controls (cells with known response patterns)

• Perform siRNA knockdown of WSTF to confirm specificity

• Use recombinant H2A.X proteins from the species of interest as standards

• Consider complementary detection methods to corroborate findings

By carefully addressing these considerations, researchers can generate more reliable and translatable data when studying Phospho-H2A.X (Tyr142) across different biological systems .

What are emerging areas of investigation regarding the role of Phospho-H2A.X (Tyr142) beyond DNA damage response?

While Phospho-H2A.X (Tyr142) has been primarily studied in the context of DNA damage response, several emerging areas of investigation suggest broader biological roles:

Transcriptional Regulation:

• Evidence suggests that the Tyr142 phosphorylation state may influence local chromatin structure and accessibility

• Potential involvement in regulating gene expression programs independent of DNA damage

• Possible role in developmental gene regulation through interaction with chromatin remodeling complexes

Cell Cycle Progression:

• Preliminary data indicate fluctuations in Tyr142 phosphorylation during normal cell cycle progression

• Potential function in S-phase regulation beyond the traditional DNA damage response

• Possible coordination with other histone modifications in maintaining genomic stability during replication

Cellular Differentiation:

• Emerging evidence suggests dynamic regulation of Tyr142 phosphorylation during cellular differentiation

• Potential involvement in lineage commitment decisions through chromatin reorganization

• Possible role in establishing cell-type-specific chromatin landscapes

Aging and Senescence:

• Early investigations point to alterations in the Tyr142 phosphorylation balance during cellular aging

• Potential contribution to age-related genomic instability

• Possible involvement in senescence-associated chromatin reorganization

Neurological Functions:

• The involvement of MCPH1 (which recognizes both phosphorylation states) in microcephaly suggests neurological implications

• Potential role in neuronal differentiation and brain development

• Possible function in maintaining genomic stability in post-mitotic neurons

These emerging areas represent promising directions for future research that may reveal novel functions of Phospho-H2A.X (Tyr142) beyond its established role in DNA damage signaling .

How might single-cell analysis technologies advance our understanding of Phospho-H2A.X (Tyr142) dynamics?

Single-cell analysis technologies offer transformative potential for advancing our understanding of Phospho-H2A.X (Tyr142) dynamics:

Single-Cell Imaging Technologies:

• Live-cell imaging with phospho-specific fluorescent reporters can track real-time dynamics of Tyr142 phosphorylation

• Super-resolution microscopy techniques (STORM, PALM) can reveal nanoscale spatial organization of modified H2A.X

• Correlative light and electron microscopy can connect phosphorylation patterns with ultrastructural chromatin changes

• High-content imaging coupled with machine learning can identify subtle phenotypic effects of Tyr142 phosphorylation state

Single-Cell 'Omics Approaches:

• Single-cell CUT&Tag or CUT&RUN can map genome-wide distribution of Phospho-H2A.X (Tyr142)

• Single-cell proteomics can identify cell-to-cell variations in the H2A.X modification network

• Single-cell RNA-seq paired with phosphorylation analysis can link transcriptional responses to Tyr142 status

• Spatial transcriptomics can correlate Tyr142 phosphorylation with localized gene expression patterns

Microfluidic Technologies:

• Droplet-based systems can isolate individual cells for precise temporal analysis following DNA damage

• Microfluidic devices can deliver controlled DNA damage while monitoring phosphorylation dynamics

• Single-cell sorting based on phosphorylation status can isolate subpopulations for downstream analysis

• Microfluidic antibody-based detection systems can quantify phosphorylation levels in minimal samples

Computational Integration:

• Advanced trajectory inference algorithms can map phosphorylation state transitions at single-cell resolution

• Machine learning approaches can identify patterns in phosphorylation dynamics not apparent in population averages

• Mathematical modeling can predict individual cell fate based on phosphorylation kinetics

• Network analysis can integrate phosphorylation data with other cellular parameters

These single-cell technologies promise to reveal heterogeneity in Tyr142 phosphorylation responses that may be masked in bulk analyses, potentially uncovering new regulatory mechanisms and cellular decision points based on this modification .

What therapeutic potentials exist in targeting the Tyr142 phosphorylation pathway in disease contexts?

The Tyr142 phosphorylation pathway presents several promising therapeutic opportunities across multiple disease contexts:

Cancer Therapy Enhancement:

• Modulating Tyr142 phosphorylation may sensitize cancer cells to existing DNA-damaging therapies

• Inhibiting WSTF kinase activity could potentially shift cellular response toward apoptosis rather than repair

• Targeting EYA phosphatases might prevent dephosphorylation, maintaining the pro-apoptotic signal

• Combination approaches targeting both Ser139 and Tyr142 modification pathways could overcome resistance mechanisms

Neurodegenerative Disease:

• Given the role of MCPH1 in recognizing phosphorylation states of H2A.X and its connection to microcephaly, targeting this pathway may have neuroprotective effects

• Modulating Tyr142 phosphorylation could potentially enhance DNA repair in neurons exposed to oxidative stress

• Preventing excessive Tyr142 dephosphorylation might help maintain genomic stability in aging neurons

• Therapeutic approaches could be developed to address the DNA damage accumulation characteristic of many neurodegenerative conditions

Aging-Related Conditions:

• Interventions targeting age-related changes in the Tyr142 phosphorylation balance may address genomic instability

• Enhancing repair pathway selection through Tyr142 modulation could potentially slow aspects of cellular aging

• Combination approaches targeting multiple histone modifications involved in DNA damage response might have synergistic effects

• Targeting specific cell populations with altered Tyr142 phosphorylation could address age-related pathologies

Inflammatory Diseases:

• Emerging evidence suggests connections between DNA damage signaling and inflammatory responses

• Modulating Tyr142 phosphorylation may influence cell death decisions in inflammatory contexts

• Targeting this pathway could potentially reduce tissue damage in conditions with excessive cell death

• Therapeutic approaches may help balance repair versus apoptosis in chronic inflammatory conditions

These therapeutic opportunities remain largely theoretical at present, requiring further research to validate targets and develop specific modulators. The complex interplay between Tyr142 and Ser139 phosphorylation presents both challenges and opportunities for drug development, potentially allowing for precise modulation of cellular responses to DNA damage in disease contexts .

How has our understanding of Phospho-H2A.X (Tyr142) evolved in recent years?

The identification of this "phosphorylation switch" mechanism revealed that H2A.X signaling involves a sophisticated temporal coding system rather than simple on/off signaling. The recognition that the diphosphorylated state (pSer139/pTyr142) may promote apoptotic responses while the monophosphorylated state (pSer139) facilitates DNA repair has added crucial nuance to our understanding of how cells determine their fate following genomic damage .

Furthermore, the discovery that MCPH1 can recognize both phosphorylation states via its tandem BRCT domains has provided mechanistic insight into how cells interpret these modifications . This finding connects H2A.X phosphorylation to the broader chromatin response system and explains how early damage response proteins can maintain association with damaged sites throughout the transition from damage detection to repair initiation.

Recent research has also begun to explore potential functions beyond canonical DNA damage response, suggesting roles in transcriptional regulation, cell cycle progression, and development. These advances collectively represent a paradigm shift from viewing H2A.X modifications as simple damage markers to understanding them as sophisticated regulatory signals that coordinate multiple cellular processes and fate decisions.

What key questions remain unanswered in the field of Phospho-H2A.X (Tyr142) research?

Despite significant advances, several key questions remain unanswered in Phospho-H2A.X (Tyr142) research:

Mechanistic Questions:

• What is the precise mechanism by which the diphosphorylated versus monophosphorylated states differentially recruit repair or apoptotic factors?

• How do other histone modifications interact with Tyr142 phosphorylation to create a comprehensive "histone code" for DNA damage?

• What determines the rate of Tyr142 dephosphorylation following damage, and how is this process regulated?

• How does the chromatin context influence the phosphorylation dynamics of Tyr142?

Physiological Questions:

• What is the physiological significance of constitutive Tyr142 phosphorylation in undamaged cells?

• How does the Tyr142 phosphorylation status vary across different tissues and developmental stages?

• What role does this modification play in normal cellular processes beyond the DNA damage response?

• How does cellular metabolism influence the kinetics of Tyr142 phosphorylation/dephosphorylation?

Disease-Related Questions:

• How is the Tyr142 phosphorylation pathway dysregulated in cancer and other diseases?

• Can alterations in this pathway contribute to neurodevelopmental disorders, particularly given MCPH1's role in microcephaly?

• How does aging affect the balance and dynamics of Tyr142 phosphorylation?

• Can therapeutic targeting of this pathway effectively modulate cellular responses to damage?

Technical Questions:

• How can we develop more specific tools to distinguish between the different phosphorylation states of H2A.X?

• What approaches can capture the dynamic interplay between Ser139 and Tyr142 phosphorylation at single-cell resolution?

• How can we effectively map genome-wide distribution patterns of Tyr142 phosphorylation?